Your session is about to expire
← Back to Search
Withania somnifera for Lou Gehrig's Disease (NIALS Trial)
Phase 2
Waitlist Available
Led By Agessandro Abrahao, MD, MSc
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 9 weeks
Summary
This is a Phase II, single centre, randomized, parallel, double blind, placebo-controlled clinical trial to determine the safety of Withania somnifera in participants with Amyotrophic Lateral Sclerosis (ALS).
Eligible Conditions
- Lou Gehrig's Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 9 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 9 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of adverse events (safety)
Secondary study objectives
Change in RMT values
Change in SICI values
Change in recovery cycle
+1 moreOther study objectives
Change in serum IL-6 levels
Incident cases of ALSFRS-R score changes of 4 or more points
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Medium dosage Withania somniferaExperimental Treatment1 Intervention
272mg oral twice a day
Group II: High dosage Withania somniferaExperimental Treatment1 Intervention
544mg oral twice a day
Group III: PlaceboPlacebo Group1 Intervention
Matched capsules twice a day
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
674 Previous Clinical Trials
1,565,780 Total Patients Enrolled
Agessandro Abrahao, MD, MScPrincipal InvestigatorSunnybrook Research Institute, University of Toronto
2 Previous Clinical Trials
17 Total Patients Enrolled
Lorne Zinman, MD, MScStudy DirectorSunnybrook Research Institute, University of Toronto
Share this study with friends
Copy Link
Messenger